首页 > 最新文献

Phytomedicine最新文献

英文 中文
SQYC formula improves the efficacy of PD-1 monoclonal antibodies in MSS colorectal cancer by regulating dendritic cell mitophagy via the PINK1-Parkin pathway SQYC方通过PINK1-Parkin通路调节树突状细胞有丝分裂,提高PD-1单克隆抗体在MSS结直肠癌中的疗效。
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-11 DOI: 10.1016/j.phymed.2025.156388
Hong Wang , Yi Ji , Shan Deng , Xiao ying Qin , Xie tao Ye , Ye yang Sun , Xiao yu Che , Lin Yang , Chu yue Huang , Yan Chen , Yu ping Liu

Background

Microsatellite stable (MSS) colorectal carcinomas (CRCs) exhibit poor responsiveness to immunotherapy such as immune checkpoint inhibitors (ICIs). In the realm of clinical cancer treatment, traditional Chinese medicines (TCMs) are extensively utilized for their immunomodulatory properties. Shen Qi Yi Chang (SQYC), a clinical prescription for CRC treatment, improve the life quality of CRC patients and enhance their immune function.

Purpose

This study was to reveal the effect and mechanism of SQYC in improving the effect of PD-1 inhibitors in the treatment of MSS-type CRC.

Methods

CT26-luc in situ CRC tumor model and human CRC organoid model was established to evaluate the anti-tumor efficacy of SQYC combined with PD-1 inhibitor. Flow cytometry analysis was utilized to investigate the effect of SQYC on the infiltration and immune function of TILs and DCs in the immune microenvironment. Following this, RNA sequencing analysis, seahorse, TEM and immunofluorescence were performed to regulation of SQYC on mitophagy in DCs cells. UPLC-Q-TOF/MS and molecular docking were used to reveal the key blood-entering components of SQYC-regulated PINK1-parkin pathway.

Results

The SQYC-containing serum improved the efficacy of sintilimab in MSS CRC organoid model. After combined administration of 11.4 g/kg/day SQYC extract and 5 mg/kg α-PD-1, it was observed that SQYC enhanced the efficacy of PD-1 inhibitor against MSS CRC. Flow cytometry and immunofluorescence analysis revealed an augmented infiltration of tumor-infiltrating lymphocytes (TILs) and an improved antigen presentation function of dendritic cells (DCs). Notably, RNA sequencing analysis demonstrated an evident correlation with mitochondrial function related pathways following SQYC treatment. Mechanistically, SQYC promoted mitophagy in DCs via the PINK1-Parkin pathway, thereby improving mitochondrial quality, energy metabolism, and mitochondrial dynamics. Evaluation of the blood components of SQYC coupled with molecular docking, demonstrated good binding affinity with PINK1/PARKIN/LC3.

Conclusion

Our findings highlight SQYC as a promising candidate for improving immunotherapy in MSS CRC, suggesting that targeting PINK1-Parkin in DCs could represent a novel strategy for improving the efficacy of ICIs. Furthermore, it provides new theoretical and scientific underpinnings to enhance the clinical efficacy of immunosuppressants.
背景:微卫星稳定型(MSS)结直肠癌(crc)对免疫检查点抑制剂(ICIs)等免疫疗法的反应性较差。在临床肿瘤治疗领域,中药因其免疫调节特性被广泛应用。参气益肠(SQYC)是一种治疗结直肠癌的临床处方,改善结直肠癌患者的生活质量,增强其免疫功能。目的:本研究旨在揭示SQYC在改善PD-1抑制剂治疗mss型结直肠癌中的作用及其机制。方法:建立CT26-luc原位CRC肿瘤模型和人CRC类器官模型,评价SQYC联合PD-1抑制剂的抗肿瘤效果。采用流式细胞术分析SQYC对免疫微环境中TILs和DCs浸润及免疫功能的影响。随后,采用RNA测序、海马、透射电镜和免疫荧光等方法研究SQYC对DCs细胞有丝分裂的调控作用。通过UPLC-Q-TOF/MS和分子对接,揭示了sqyc调控的PINK1-parkin通路的关键血液进入成分。结果:含sqyc的血清提高了辛替单抗在MSS CRC类器官模型中的疗效。经11.4 g/kg/d的SQYC提取物和5 mg/kg的α-PD-1联合给药后,观察到SQYC可增强PD-1抑制剂对MSS CRC的抑制作用。流式细胞术和免疫荧光分析显示肿瘤浸润淋巴细胞(TILs)浸润增强,树突状细胞(dc)抗原呈递功能增强。值得注意的是,RNA测序分析显示,SQYC治疗后,线粒体功能相关通路明显相关。在机制上,SQYC通过PINK1-Parkin途径促进DCs的线粒体自噬,从而改善线粒体质量、能量代谢和线粒体动力学。通过分子对接对SQYC血液成分进行评价,证实其与PINK1/PARKIN/LC3具有良好的结合亲和力。结论:我们的研究结果强调SQYC是改善MSS结直肠癌免疫治疗的一个有希望的候选药物,这表明在dc中靶向PINK1-Parkin可能是提高ICIs疗效的一种新策略。为提高免疫抑制剂的临床疗效提供了新的理论和科学依据。
{"title":"SQYC formula improves the efficacy of PD-1 monoclonal antibodies in MSS colorectal cancer by regulating dendritic cell mitophagy via the PINK1-Parkin pathway","authors":"Hong Wang ,&nbsp;Yi Ji ,&nbsp;Shan Deng ,&nbsp;Xiao ying Qin ,&nbsp;Xie tao Ye ,&nbsp;Ye yang Sun ,&nbsp;Xiao yu Che ,&nbsp;Lin Yang ,&nbsp;Chu yue Huang ,&nbsp;Yan Chen ,&nbsp;Yu ping Liu","doi":"10.1016/j.phymed.2025.156388","DOIUrl":"10.1016/j.phymed.2025.156388","url":null,"abstract":"<div><h3>Background</h3><div>Microsatellite stable (MSS) colorectal carcinomas (CRCs) exhibit poor responsiveness to immunotherapy such as immune checkpoint inhibitors (ICIs). In the realm of clinical cancer treatment, traditional Chinese medicines (TCMs) are extensively utilized for their immunomodulatory properties. Shen Qi Yi Chang (SQYC), a clinical prescription for CRC treatment, improve the life quality of CRC patients and enhance their immune function.</div></div><div><h3>Purpose</h3><div>This study was to reveal the effect and mechanism of SQYC in improving the effect of PD-1 inhibitors in the treatment of MSS-type CRC.</div></div><div><h3>Methods</h3><div>CT26-luc <em>in situ</em> CRC tumor model and human CRC organoid model was established to evaluate the anti-tumor efficacy of SQYC combined with PD-1 inhibitor. Flow cytometry analysis was utilized to investigate the effect of SQYC on the infiltration and immune function of TILs and DCs in the immune microenvironment. Following this, RNA sequencing analysis, seahorse, TEM and immunofluorescence were performed to regulation of SQYC on mitophagy in DCs cells. UPLC-Q-TOF/MS and molecular docking were used to reveal the key blood-entering components of SQYC-regulated PINK1-parkin pathway.</div></div><div><h3>Results</h3><div>The SQYC-containing serum improved the efficacy of sintilimab in MSS CRC organoid model. After combined administration of 11.4 g/kg/day SQYC extract and 5 mg/kg α-PD-1, it was observed that SQYC enhanced the efficacy of PD-1 inhibitor against MSS CRC. Flow cytometry and immunofluorescence analysis revealed an augmented infiltration of tumor-infiltrating lymphocytes (TILs) and an improved antigen presentation function of dendritic cells (DCs). Notably, RNA sequencing analysis demonstrated an evident correlation with mitochondrial function related pathways following SQYC treatment. Mechanistically, SQYC promoted mitophagy in DCs via the PINK1-Parkin pathway, thereby improving mitochondrial quality, energy metabolism, and mitochondrial dynamics. Evaluation of the blood components of SQYC coupled with molecular docking, demonstrated good binding affinity with PINK1/PARKIN/LC3.</div></div><div><h3>Conclusion</h3><div>Our findings highlight SQYC as a promising candidate for improving immunotherapy in MSS CRC, suggesting that targeting PINK1-Parkin in DCs could represent a novel strategy for improving the efficacy of ICIs. Furthermore, it provides new theoretical and scientific underpinnings to enhance the clinical efficacy of immunosuppressants.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"138 ","pages":"Article 156388"},"PeriodicalIF":6.7,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnessing natural saponins: Advancements in mitochondrial dysfunction and therapeutic applications
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-10 DOI: 10.1016/j.phymed.2025.156383
Hongmei Liu , Huan Wang , Xinyu Lin , Min Xu , Wenying Lan , Jinlian Wang

Background

Mitochondrial dysfunction plays a crucial role in the development of a variety of diseases, notably neurodegenerative disorders, cardiovascular diseases, metabolic syndrome, and cancer. Natural saponins, which are intricate glycosides characterized by steroidal or triterpenoid structures, have attracted interest due to their diverse pharmacological benefits, including anti-inflammatory, antiviral, and anti-aging effects.

Purpose

This review synthesizes recent advancements in understanding mitochondrial dysfunction and explores how saponins can modulate mitochondrial function. It focuses on their potential applications in neuroprotection, cardiovascular health, and oncology.

Study design

The review incorporates a comprehensive literature analysis, highlighting the interplay between saponins and mitochondrial signaling pathways. Specific attention is given to the effects of saponins like ginsenoside Rg2 and 20(S)-protopanaxatriol on mitophagy and their neuroprotective, anti-aging, and synergistic therapeutic effects when combined.

Methods

We conducted a comprehensive review of current research and clinical trials using PubMed, Google Scholar, and SciFinder databases. The search focused on saponins' role in mitochondrial function and their therapeutic effects, including "saponins", "mitochondria" and "mitochondrial function". The analysis primarily focused on articles published between 2011 and 2024.

Results

The findings indicate that certain saponins can enhance mitophagy and modulate mitochondrial signaling pathways, showing promise in neuroprotection and anti-aging. Additionally, combinations of saponins have demonstrated synergistic effects in myocardial protection and cancer therapy, potentially improving therapeutic outcomes.

Conclusion

Although saponins exhibit significant potential in modulating mitochondrial functions and developing innovative therapeutic strategies, their clinical applications are constrained by low bioavailability. Rigorous clinical trials are essential to translate these findings into effective clinical therapies, ultimately improving patient outcomes through a deeper understanding of saponins’ impact on mitochondrial function.
{"title":"Harnessing natural saponins: Advancements in mitochondrial dysfunction and therapeutic applications","authors":"Hongmei Liu ,&nbsp;Huan Wang ,&nbsp;Xinyu Lin ,&nbsp;Min Xu ,&nbsp;Wenying Lan ,&nbsp;Jinlian Wang","doi":"10.1016/j.phymed.2025.156383","DOIUrl":"10.1016/j.phymed.2025.156383","url":null,"abstract":"<div><h3>Background</h3><div>Mitochondrial dysfunction plays a crucial role in the development of a variety of diseases, notably neurodegenerative disorders, cardiovascular diseases, metabolic syndrome, and cancer. Natural saponins, which are intricate glycosides characterized by steroidal or triterpenoid structures, have attracted interest due to their diverse pharmacological benefits, including anti-inflammatory, antiviral, and anti-aging effects.</div></div><div><h3>Purpose</h3><div>This review synthesizes recent advancements in understanding mitochondrial dysfunction and explores how saponins can modulate mitochondrial function. It focuses on their potential applications in neuroprotection, cardiovascular health, and oncology.</div></div><div><h3>Study design</h3><div>The review incorporates a comprehensive literature analysis, highlighting the interplay between saponins and mitochondrial signaling pathways. Specific attention is given to the effects of saponins like ginsenoside Rg2 and 20(S)-protopanaxatriol on mitophagy and their neuroprotective, anti-aging, and synergistic therapeutic effects when combined.</div></div><div><h3>Methods</h3><div>We conducted a comprehensive review of current research and clinical trials using PubMed, Google Scholar, and SciFinder databases. The search focused on saponins' role in mitochondrial function and their therapeutic effects, including \"saponins\", \"mitochondria\" and \"mitochondrial function\". The analysis primarily focused on articles published between 2011 and 2024.</div></div><div><h3>Results</h3><div>The findings indicate that certain saponins can enhance mitophagy and modulate mitochondrial signaling pathways, showing promise in neuroprotection and anti-aging. Additionally, combinations of saponins have demonstrated synergistic effects in myocardial protection and cancer therapy, potentially improving therapeutic outcomes.</div></div><div><h3>Conclusion</h3><div>Although saponins exhibit significant potential in modulating mitochondrial functions and developing innovative therapeutic strategies, their clinical applications are constrained by low bioavailability. Rigorous clinical trials are essential to translate these findings into effective clinical therapies, ultimately improving patient outcomes through a deeper understanding of saponins’ impact on mitochondrial function.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"138 ","pages":"Article 156383"},"PeriodicalIF":6.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redox imbalance driven epigenetic reprogramming and cardiovascular dysfunctions: phytocompounds for prospective epidrugs 氧化还原失衡驱动的表观遗传重编程和心血管功能障碍:植物化合物用于潜在的外源性药物。
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-10 DOI: 10.1016/j.phymed.2025.156380
Subham Saraswata Jyotirmaya , Suvasmita Rath , Jagneshwar Dandapat
<div><h3>Background</h3><div>Cardiovascular diseases (CVDs) are the major contributor to global mortality and are gaining incremental attention following the COVID-19 outbreak. Epigenetic events such as DNA methylation, histone modifications, and non-coding RNAs have a significant impact on the incidence and onset of CVDs. Altered redox status is one of the major causative factors that regulate epigenetic pathways linked to CVDs. Various bioactive phytocompounds used in alternative therapies including Traditional Chinese Medicines (TCM) regulate redox balance and epigenetic phenomena linked to CVDs. Phytocompound-based medications are in the limelight for the development of cost-effective drugs with the least side effects, which will have immense therapeutic applications.</div></div><div><h3>Purpose</h3><div>This review comprehends certain risk factors associated with CVDs and triggered by oxidative stress-driven epigenetic remodelling. Further, it critically evaluates the pharmacological efficacy of phytocompounds as inhibitors of HAT/HDAC and DNMTs as well as miRNAs regulator that lowers the incidence of CVDs, aiming for new candidates as prospective epidrugs.</div></div><div><h3>Methods</h3><div>PRISMA flow approach has been adopted for systematic literature review. Different Journals, computational databases, search engines such as Google Scholar, PubMed, Science Direct, Scopus, and ResearchGate were used to collect online information for literature survey. Statistical information collected from the World Health Organization (WHO) site (<span><span>https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)</span><svg><path></path></svg></span>) and the American Heart Association of Heart Disease and Stroke reported the international and national status of CVDs.</div></div><div><h3>Results</h3><div>The meta-analysis of various studies is elucidated in the literature, shedding light on major risk factors such as socioeconomic parameters, which contribute highly to redox imbalance, epigenetic modulations, and CVDs. Going forward, redox imbalance driven epigenetic regulations include changes in DNA methylation status, histone modifications and non-coding RNAs expression pattern which further regulates global as well as promoter modification of various transcription factors leading to the onset of CVDs. Further, the role of various bioactive compounds used in herbal medicine, including TCM for redox regulation and epigenetic modifications are discussed. Pharmacological safety doses and different phases of clinical trials of these phytocompounds are elaborated on, which shed light on the acceptance of these phytocompounds as prospective drugs.</div></div><div><h3>Conclusion</h3><div>This review suggests a strong linkage between therapeutic and preventive measures against CVDs by targeting redox imbalance-driven epigenetic reprogramming using phytocompounds as prospective epidrugs. Future in-depth research is required to evaluat
背景:心血管疾病(cvd)是全球死亡的主要原因,在2019冠状病毒病(COVID-19)爆发后,心血管疾病越来越受到关注。表观遗传事件如DNA甲基化、组蛋白修饰和非编码rna对心血管疾病的发病率和发病有重要影响。氧化还原状态的改变是调节与心血管疾病相关的表观遗传途径的主要致病因素之一。包括中药在内的替代疗法中使用的各种生物活性植物化合物可调节与心血管疾病相关的氧化还原平衡和表观遗传现象。以植物化合物为基础的药物因开发具有成本效益且副作用最小的药物而备受关注,这将具有巨大的治疗应用。目的:本文综述了氧化应激驱动的表观遗传重塑与心血管疾病相关的某些危险因素。此外,该研究还批判性地评估了植物化合物作为HAT/HDAC和dnmt抑制剂以及降低心血管疾病发病率的mirna调节剂的药理功效,旨在寻找新的候选药物作为潜在的外用药物。方法:采用PRISMA流法进行系统文献复习。使用不同的期刊、计算数据库、谷歌Scholar、PubMed、Science Direct、Scopus、ResearchGate等搜索引擎收集在线信息进行文献调查。从世界卫生组织(世卫组织)网站(https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)和美国心脏病和中风心脏协会收集的统计信息报告了心血管疾病的国际和国家状况。结果:文献中对各种研究进行了荟萃分析,揭示了主要的风险因素,如社会经济参数,这些因素对氧化还原失衡、表观遗传调节和心血管疾病的影响很大。展望未来,氧化还原失衡驱动的表观遗传调控包括DNA甲基化状态、组蛋白修饰和非编码rna表达模式的改变,这些改变进一步调控了各种转录因子的全局和启动子修饰,从而导致cvd的发生。此外,还讨论了草药中使用的各种生物活性化合物在氧化还原调节和表观遗传修饰方面的作用。阐述了这些植物化合物的药理学安全剂量和临床试验的不同阶段,从而阐明了这些植物化合物作为有前景的药物的接受程度。结论:这篇综述表明,利用植物化合物作为潜在的外用药,靶向氧化还原失衡驱动的表观遗传重编程,治疗和预防心血管疾病之间存在很强的联系。未来的深入研究需要评估CVD进展过程中植物化合物介导的表观遗传重编程和氧化应激管理背后可能的分子机制。
{"title":"Redox imbalance driven epigenetic reprogramming and cardiovascular dysfunctions: phytocompounds for prospective epidrugs","authors":"Subham Saraswata Jyotirmaya ,&nbsp;Suvasmita Rath ,&nbsp;Jagneshwar Dandapat","doi":"10.1016/j.phymed.2025.156380","DOIUrl":"10.1016/j.phymed.2025.156380","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Cardiovascular diseases (CVDs) are the major contributor to global mortality and are gaining incremental attention following the COVID-19 outbreak. Epigenetic events such as DNA methylation, histone modifications, and non-coding RNAs have a significant impact on the incidence and onset of CVDs. Altered redox status is one of the major causative factors that regulate epigenetic pathways linked to CVDs. Various bioactive phytocompounds used in alternative therapies including Traditional Chinese Medicines (TCM) regulate redox balance and epigenetic phenomena linked to CVDs. Phytocompound-based medications are in the limelight for the development of cost-effective drugs with the least side effects, which will have immense therapeutic applications.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;This review comprehends certain risk factors associated with CVDs and triggered by oxidative stress-driven epigenetic remodelling. Further, it critically evaluates the pharmacological efficacy of phytocompounds as inhibitors of HAT/HDAC and DNMTs as well as miRNAs regulator that lowers the incidence of CVDs, aiming for new candidates as prospective epidrugs.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;PRISMA flow approach has been adopted for systematic literature review. Different Journals, computational databases, search engines such as Google Scholar, PubMed, Science Direct, Scopus, and ResearchGate were used to collect online information for literature survey. Statistical information collected from the World Health Organization (WHO) site (&lt;span&gt;&lt;span&gt;https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)&lt;/span&gt;&lt;svg&gt;&lt;path&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt;) and the American Heart Association of Heart Disease and Stroke reported the international and national status of CVDs.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The meta-analysis of various studies is elucidated in the literature, shedding light on major risk factors such as socioeconomic parameters, which contribute highly to redox imbalance, epigenetic modulations, and CVDs. Going forward, redox imbalance driven epigenetic regulations include changes in DNA methylation status, histone modifications and non-coding RNAs expression pattern which further regulates global as well as promoter modification of various transcription factors leading to the onset of CVDs. Further, the role of various bioactive compounds used in herbal medicine, including TCM for redox regulation and epigenetic modifications are discussed. Pharmacological safety doses and different phases of clinical trials of these phytocompounds are elaborated on, which shed light on the acceptance of these phytocompounds as prospective drugs.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;This review suggests a strong linkage between therapeutic and preventive measures against CVDs by targeting redox imbalance-driven epigenetic reprogramming using phytocompounds as prospective epidrugs. Future in-depth research is required to evaluat","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"138 ","pages":"Article 156380"},"PeriodicalIF":6.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shouhui Tongbian Capsule ameliorates obesity by enhancing energy consumption and promoting lipolysis via cAMP-PKA pathway
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-07 DOI: 10.1016/j.phymed.2025.156375
Kaiyi Wu , Jiangying Kuang , Nana Huang , Lisong Sheng , Jianchao Li , Rongrong Li , Liping Gong , Qinghua Lu , Runping Liu , Rong Sun

Background

The prevalence of obesity and its associated diseases has sharply increased, becoming a global health issue. White adipose tissue (WAT), responsible for lipid storage via hyperplasia and hypertrophy, and brown adipose tissue (BAT), which facilitates energy dissipation, have increasingly been recognized as critical regulators of weight loss. Shouhui Tongbian Capsule (SHTB) has traditionally been used for detoxification, weight loss, and lipid reduction, and clinical evidence supports its use for relieving constipation. In traditional Chinese medicine (TCM), "dissipating turbidity" is seen as a shared approach to treating both constipation and obesity. Our evidence suggests that SHTB improves obesity and metabolic disorders, but the underlying mechanisms remain unclear.

Purpose

This study aimed to evaluate the pharmacological effects of SHTB on obesity and to explore the underlying mechanisms involved.

Methods

Obese mice induced by a high-fat diet were treated with SHTB, and effects on body weight, adipose tissue, and metabolism were assessed. Active ingredients were identified through UPLC-MS, while metabolomics and RNA sequencing were performed to explore the mechanisms of SHTB in obesity, and molecular biology techniques validated its effects on energy consumption and lipolysis in adipose tissue. Finally, rescue experiments in vivo and in vitro confirmed the proposed mechanisms.

Results

SHTB significantly reduced body weight, body fat percentage, and WAT mass while increasing BAT weight, and enhancing energy expenditure. Metabolomics and RNA sequencing indicated activation of the G-protein coupled receptor signaling and cAMP-PKA pathway, leading to increased lipolysis in WAT and enhanced thermogenesis in BAT. H89, a PKA agonist, counteracted these effects, supporting the involvement of cAMP-PKA signaling.

Conclusion

SHTB may prevent obesity by promoting lipolysis and enhancing BAT thermogenesis via the cAMP-PKA pathway, offering a potential therapeutic approach for obesity management.
{"title":"Shouhui Tongbian Capsule ameliorates obesity by enhancing energy consumption and promoting lipolysis via cAMP-PKA pathway","authors":"Kaiyi Wu ,&nbsp;Jiangying Kuang ,&nbsp;Nana Huang ,&nbsp;Lisong Sheng ,&nbsp;Jianchao Li ,&nbsp;Rongrong Li ,&nbsp;Liping Gong ,&nbsp;Qinghua Lu ,&nbsp;Runping Liu ,&nbsp;Rong Sun","doi":"10.1016/j.phymed.2025.156375","DOIUrl":"10.1016/j.phymed.2025.156375","url":null,"abstract":"<div><h3>Background</h3><div>The prevalence of obesity and its associated diseases has sharply increased, becoming a global health issue. White adipose tissue (WAT), responsible for lipid storage via hyperplasia and hypertrophy, and brown adipose tissue (BAT), which facilitates energy dissipation, have increasingly been recognized as critical regulators of weight loss. Shouhui Tongbian Capsule (SHTB) has traditionally been used for detoxification, weight loss, and lipid reduction, and clinical evidence supports its use for relieving constipation. In traditional Chinese medicine (TCM), \"dissipating turbidity\" is seen as a shared approach to treating both constipation and obesity. Our evidence suggests that SHTB improves obesity and metabolic disorders, but the underlying mechanisms remain unclear.</div></div><div><h3>Purpose</h3><div>This study aimed to evaluate the pharmacological effects of SHTB on obesity and to explore the underlying mechanisms involved.</div></div><div><h3>Methods</h3><div>Obese mice induced by a high-fat diet were treated with SHTB, and effects on body weight, adipose tissue, and metabolism were assessed. Active ingredients were identified through UPLC-MS, while metabolomics and RNA sequencing were performed to explore the mechanisms of SHTB in obesity, and molecular biology techniques validated its effects on energy consumption and lipolysis in adipose tissue. Finally, rescue experiments <em>in vivo and in vitro</em> confirmed the proposed mechanisms.</div></div><div><h3>Results</h3><div>SHTB significantly reduced body weight, body fat percentage, and WAT mass while increasing BAT weight, and enhancing energy expenditure. Metabolomics and RNA sequencing indicated activation of the G-protein coupled receptor signaling and cAMP-PKA pathway, leading to increased lipolysis in WAT and enhanced thermogenesis in BAT. H89, a PKA agonist, counteracted these effects, supporting the involvement of cAMP-PKA signaling.</div></div><div><h3>Conclusion</h3><div>SHTB may prevent obesity by promoting lipolysis and enhancing BAT thermogenesis via the cAMP-PKA pathway, offering a potential therapeutic approach for obesity management.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"138 ","pages":"Article 156375"},"PeriodicalIF":6.7,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-colorectal cancer actions of Glycyrrhiza uralensis Fisch. and its underlying mechanism via HPLC integration and network pharmacological approaches 甘草的抗大肠癌作用。通过高效液相色谱整合和网络药理学方法研究其潜在机制。
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-06 DOI: 10.1016/j.phymed.2025.156370
Hong Duan , Wei Wang , Ying Shi , Li Wang , Ghulam Jilany Khan , Mengmeng Luo , Jing Zhou , Jianhua Yang , Chenghui He , Fei Li , Henggui Hu , Kefeng Zhai

Background

The therapeutic and prognostic outcomes for colorectal cancer (CRC) remain unsatisfactory. Among multiple reported bioactive functionalities of Glycyrrhiza uralensis Fisch. one vital recently reported activity is its therapeutic role against numerous cancers but limited information is available related to its underlying key mechanisms and therapeutically active ingredients, especially against CRC treatment.

Objective

The aim of current study aims is to reconnoiter G. uralensis pharmacological basis and primary molecular mode of action in treating CRC.

Methods

For examining the G. uralensis active ingredients and underlying mechanism investigation against CRC including, potential anti-CRC phytochemicals, targets, and related signaling pathways, HPLC and Network-pharmacology analysis techniques was employed, respectively. Whereas, for binding capabilities of active components to their targets, molecular-docking, molecular dynamic simulation technique employed and cell proliferation assays screened the best anti-CRC components, followed by biological function experiments on SW480 cells for verification. Finally, the SW480-xenograft model and subsequent related experiments further confirmed the effect of Liquiritin on CRC.

Results

Seven compounds were identified from G. uralensis through HPLC. Network pharmacology and molecular docking results indicated that G. uralensis components exhibited significant anti-cancer effects. These effects were mediated through cancer and MAPK-related signaling pathways, targeting TP53, SRC, STAT3, and PIK3CA proteins. In-vitro experiments showed that liquiritin had better anti-CRC effects compared to other components as it significantly repressed the SW480 propagation, development of colony, relocation, and invasion. Additionally, liquiritin has been shown to significantly reduce tumor size in tumor-bearing mice by targeting p53 and inhibiting the p38 MAPK pathway.

Conclusion

In G. uralensis, main API is liquiritin that target CRC tumorigeneses via inhibition of p53 and p38 MAPK, thus can be used for CRC therapy. The findings provide a solid pharmacological basis and potential therapeutic targets for G. uralensis in the treatment of CRC.
背景:结直肠癌(CRC)的治疗和预后结果仍然不令人满意。在已报道的多种甘草生物活性功能中。最近报道的一项重要活动是其对许多癌症的治疗作用,但有关其潜在关键机制和治疗活性成分的信息有限,特别是针对结直肠癌治疗。目的:探讨乌拉尔草治疗结直肠癌的药理基础和主要分子作用方式。方法:分别采用高效液相色谱(HPLC)和网络药理学(Network-pharmacology)分析技术,检测乌拉尔根有效成分,探讨其抗CRC作用机制,包括潜在的抗CRC植物化学物质、靶点和相关信号通路。而对于活性成分与靶标的结合能力,通过分子对接、分子动力学模拟技术和细胞增殖实验筛选了最佳的抗crc成分,并在SW480细胞上进行了生物学功能实验验证。最后,sw480 -异种移植模型及后续相关实验进一步证实了Liquiritin对CRC的作用。结果:高效液相色谱法从乌拉尔草中鉴定出7个化合物。网络药理学和分子对接结果表明,乌拉尔草成分具有显著的抗癌作用。这些作用是通过癌症和mapk相关信号通路介导的,靶向TP53、SRC、STAT3和PIK3CA蛋白。体外实验表明,与其他成分相比,甘草素具有更好的抗crc作用,可显著抑制SW480的繁殖、菌落发育、迁移和侵袭。此外,liquiritin已被证明可以通过靶向p53和抑制p38 MAPK通路显著减小荷瘤小鼠的肿瘤大小。结论:乌拉尔树的主要原料药为甘草素,通过抑制p53和p38 MAPK靶向结直肠癌的发生,可用于结直肠癌的治疗。这些发现为乌拉尔菌治疗结直肠癌提供了坚实的药理学基础和潜在的治疗靶点。
{"title":"Anti-colorectal cancer actions of Glycyrrhiza uralensis Fisch. and its underlying mechanism via HPLC integration and network pharmacological approaches","authors":"Hong Duan ,&nbsp;Wei Wang ,&nbsp;Ying Shi ,&nbsp;Li Wang ,&nbsp;Ghulam Jilany Khan ,&nbsp;Mengmeng Luo ,&nbsp;Jing Zhou ,&nbsp;Jianhua Yang ,&nbsp;Chenghui He ,&nbsp;Fei Li ,&nbsp;Henggui Hu ,&nbsp;Kefeng Zhai","doi":"10.1016/j.phymed.2025.156370","DOIUrl":"10.1016/j.phymed.2025.156370","url":null,"abstract":"<div><h3>Background</h3><div>The therapeutic and prognostic outcomes for colorectal cancer (CRC) remain unsatisfactory. Among multiple reported bioactive functionalities of <em>Glycyrrhiza uralensis</em> Fisch. one vital recently reported activity is its therapeutic role against numerous cancers but limited information is available related to its underlying key mechanisms and therapeutically active ingredients, especially against CRC treatment.</div></div><div><h3>Objective</h3><div>The aim of current study aims is to reconnoiter <em>G. uralensis</em> pharmacological basis and primary molecular mode of action in treating CRC.</div></div><div><h3>Methods</h3><div>For examining the <em>G. uralensis</em> active ingredients and underlying mechanism investigation against CRC including, potential anti-CRC phytochemicals, targets, and related signaling pathways, HPLC and Network-pharmacology analysis techniques was employed, respectively. Whereas, for binding capabilities of active components to their targets, molecular-docking, molecular dynamic simulation technique employed and cell proliferation assays screened the best anti-CRC components, followed by biological function experiments on SW480 cells for verification. Finally, the SW480-xenograft model and subsequent related experiments further confirmed the effect of Liquiritin on CRC.</div></div><div><h3>Results</h3><div>Seven compounds were identified from <em>G. uralensis</em> through HPLC. Network pharmacology and molecular docking results indicated that <em>G. uralensis</em> components exhibited significant anti-cancer effects. These effects were mediated through cancer and MAPK-related signaling pathways, targeting TP53, SRC, STAT3, and PIK3CA proteins. <em>In-vitro</em> experiments showed that liquiritin had better anti-CRC effects compared to other components as it significantly repressed the SW480 propagation, development of colony, relocation, and invasion. Additionally, liquiritin has been shown to significantly reduce tumor size in tumor-bearing mice by targeting p53 and inhibiting the p38 MAPK pathway.</div></div><div><h3>Conclusion</h3><div>In <em>G. uralensis</em>, main API is liquiritin that target CRC tumorigeneses via inhibition of p53 and p38 MAPK, thus can be used for CRC therapy. The findings provide a solid pharmacological basis and potential therapeutic targets for <em>G. uralensis</em> in the treatment of CRC.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"138 ","pages":"Article 156370"},"PeriodicalIF":6.7,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-inflammatory activity of essential oil from medicinal plants: An insight into molecular mechanism, in-silico studies and signaling pathways
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-02 DOI: 10.1016/j.phymed.2025.156364
Lopamudra Subudhi, Hrudayanath Thatoi, Amrita Banerjee

Background

Medicinal plants have historically been the cornerstone of treatment for a myriad of ailments. With modern pharmacology, many contemporary drugs have been derived from traditional medicine practices. Essential oils from these plants, known for their anti-inflammatory capabilities, have played a significant role in treating conditions such as cardiovascular and inflammatory skin diseases, as well as joint inflammation. This study revisits these ancient remedies to further explore their efficacy and mechanisms in the modern context.

Focus Area

This review focuses on identifying and analysing the primary phytochemical in medicinal plants that exhibit anti-inflammatory properties. The chemical classes of interest include alkaloids, polyphenols, terpenoids, flavonoids, saponins, and tannins, which are prevalent in the essential oils derived from therapeutic plants. By understanding their role in modulating molecular pathways, this study aims to highlight their potential in the treatment of inflammatory diseases.

Methods

The study employs in silico techniques such as molecular modelling and docking to examine the pharmacokinetics and toxicity profiles of selected phytochemical. This approach facilitates a deeper understanding of how these natural compounds interact at the molecular level, either as activators or inhibitors, which can influence various biochemical pathways related to inflammation.

Results

Preliminary findings suggest that specific phytochemical significantly modulate inflammatory pathways, offering potential therapeutic targets. The analysis reveals that these natural substances can effectively reduce inflammation without the adverse side effects commonly associated with synthetic drugs. The study provides a detailed characterization of the active components within essential oils and their respective anti-inflammatory actions.

Conclusion

The review underscores the immense potential for medicinal plants as a source for developing new and safer pharmaceuticals aimed at treating inflammatory conditions. By harnessing the power of natural phytochemical, there is a promising avenue for creating innovative drug therapies. This study encourages further research into the utilization of natural plant products, promoting a broader application in medicinal treatments and a return to nature-centric solutions in healthcare.
{"title":"Anti-inflammatory activity of essential oil from medicinal plants: An insight into molecular mechanism, in-silico studies and signaling pathways","authors":"Lopamudra Subudhi,&nbsp;Hrudayanath Thatoi,&nbsp;Amrita Banerjee","doi":"10.1016/j.phymed.2025.156364","DOIUrl":"10.1016/j.phymed.2025.156364","url":null,"abstract":"<div><h3>Background</h3><div>Medicinal plants have historically been the cornerstone of treatment for a myriad of ailments. With modern pharmacology, many contemporary drugs have been derived from traditional medicine practices. Essential oils from these plants, known for their anti-inflammatory capabilities, have played a significant role in treating conditions such as cardiovascular and inflammatory skin diseases, as well as joint inflammation. This study revisits these ancient remedies to further explore their efficacy and mechanisms in the modern context.</div></div><div><h3>Focus Area</h3><div>This review focuses on identifying and analysing the primary phytochemical in medicinal plants that exhibit anti-inflammatory properties. The chemical classes of interest include alkaloids, polyphenols, terpenoids, flavonoids, saponins, and tannins, which are prevalent in the essential oils derived from therapeutic plants. By understanding their role in modulating molecular pathways, this study aims to highlight their potential in the treatment of inflammatory diseases.</div></div><div><h3>Methods</h3><div>The study employs in silico techniques such as molecular modelling and docking to examine the pharmacokinetics and toxicity profiles of selected phytochemical. This approach facilitates a deeper understanding of how these natural compounds interact at the molecular level, either as activators or inhibitors, which can influence various biochemical pathways related to inflammation.</div></div><div><h3>Results</h3><div>Preliminary findings suggest that specific phytochemical significantly modulate inflammatory pathways, offering potential therapeutic targets. The analysis reveals that these natural substances can effectively reduce inflammation without the adverse side effects commonly associated with synthetic drugs. The study provides a detailed characterization of the active components within essential oils and their respective anti-inflammatory actions.</div></div><div><h3>Conclusion</h3><div>The review underscores the immense potential for medicinal plants as a source for developing new and safer pharmaceuticals aimed at treating inflammatory conditions. By harnessing the power of natural phytochemical, there is a promising avenue for creating innovative drug therapies. This study encourages further research into the utilization of natural plant products, promoting a broader application in medicinal treatments and a return to nature-centric solutions in healthcare.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"138 ","pages":"Article 156364"},"PeriodicalIF":6.7,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143041147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Yu-Xue-Bi capsule ameliorates aggressive synovitis and joint damage in rheumatoid arthritis via modulating the SUCNR1/HIF-1α/TRPV1 axis. 玉血痹胶囊通过调节SUCNR1/HIF-1α/TRPV1轴改善类风湿关节炎侵袭性滑膜炎和关节损伤。
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-01 Epub Date: 2024-12-29 DOI: 10.1016/j.phymed.2024.156354
Wenjia Chen, Chu Zhang, Mingzhu Xu, Tao Li, Xin Li, Peihao Li, Xun Gong, Yang Qu, Chunling Zhou, Xia Mao, Na Lin, Wei Liu, Quan Jiang, Haiyu Xu, Yanqiong Zhang

Background: Specific treatment for rheumatoid arthritis (RA) is still an unmet need. Yu-Xue-Bi (YXB) capsule effectively treats RA with blood stasis syndrome (BS). However, its mechanism remains unclear.

Purpose: Exploring and elucidating the therapeutic effect and pharmacological mechanism of YXB capsule in treating RA.

Methods: This study identified differentially expressed genes (DEGs) in patients with RA and BS compared to healthy controls using clinical transcriptomics data. Clinical symptoms of RA and BS, and the related genes were collected from the SoFDA and HPO databases. Candidate bioactive constituents in YXB were identified via UPLC-QTOF/MS and evaluated using ADMET rules. Putative targets were predicted, and a network linking disease-related DEGs and drug targets was constructed. Key targets were screened utilizing random walk-with-restart (RWR) algorithms and verified through experiments using rat models of collagen-induced arthritis with BS (CIA-BS model) in vivo.

Results: We found 1220 DEGs along with 976 clinical symptom-related genes, as RA with BS-related genes. Chemical profiling identified 193 YXB constituents, with 98 meeting optimal ADMET criteria. We predicted 459 putative targets for these constituents. Network calculations screened 209 key targets, 129 RA with BS-related genes and 92 YXB targets involved in immune inflammation, blood stagnation, and hyperalgesia imbalance. Notably, the SUCNR1/HIF-1α/TRPV1 axis was enriched by YXB targets against RA with BS. Experimentally, YXB inhibited inflamed joint deterioration, including synovial inflammation, cartilage damage and bone erosion, relieving mechanical and cold allodynia hyperglasia. It reversed hemorrheology and vascular function in CIA-BS rats, restoring SDHB and eNOS expression, preventing SDHA, SUCNR1 and HIF-1α activation, reducing SUCN, TNF-α and IL-1β production, and TRPV1 and TRPA1 expression.

Conclusion: Our data support YXB's therapeutic effects on aggressive RA-BS by modulating the SUCNR1/HIF-1α/TRPV1 axis.

背景:类风湿关节炎(RA)的特异性治疗仍然是一个未满足的需求。愈血痹胶囊治疗类风湿性关节炎血瘀证疗效确切。然而,其机制尚不清楚。目的:探索和阐明益泻b胶囊治疗类风湿关节炎的疗效及药理机制。方法:本研究利用临床转录组学数据鉴定了RA和BS患者与健康对照者的差异表达基因(DEGs)。从SoFDA和HPO数据库中收集RA和BS的临床症状及相关基因。通过UPLC-QTOF/MS鉴定YXB中的候选生物活性成分,并采用ADMET规则进行评价。预测了可能的靶点,并构建了疾病相关deg和药物靶点之间的网络。利用随机行走-重启(random walk-with-restart, RWR)算法筛选关键靶点,并通过胶原诱导关节炎伴BS大鼠体内模型(CIA-BS模型)进行实验验证。结果:我们发现1220个deg伴976个临床症状相关基因,如RA伴bs相关基因。化学分析鉴定出193种YXB成分,其中98种符合最佳ADMET标准。我们预测了这些成分的459个假定靶点。网络计算筛选出209个关键靶点,129个带有bs相关基因的RA和92个与免疫炎症、血瘀和痛觉过敏失调有关的YXB靶点。值得注意的是,SUCNR1/HIF-1α/TRPV1轴被YXB靶向抗RA伴BS富集。实验表明,YXB可抑制关节炎症恶化,包括滑膜炎症、软骨损伤和骨侵蚀,缓解机械和冷异常性骨质增生。它能逆转中枢神经综合征大鼠的血液流变学和血管功能,恢复SDHB和eNOS的表达,阻止SDHA、SUCNR1和HIF-1α的活化,降低SUCN、TNF-α和IL-1β的产生,以及TRPV1和TRPA1的表达。结论:YXB通过调节SUCNR1/HIF-1α/TRPV1轴对侵袭性RA-BS的治疗作用。
{"title":"Yu-Xue-Bi capsule ameliorates aggressive synovitis and joint damage in rheumatoid arthritis via modulating the SUCNR1/HIF-1α/TRPV1 axis.","authors":"Wenjia Chen, Chu Zhang, Mingzhu Xu, Tao Li, Xin Li, Peihao Li, Xun Gong, Yang Qu, Chunling Zhou, Xia Mao, Na Lin, Wei Liu, Quan Jiang, Haiyu Xu, Yanqiong Zhang","doi":"10.1016/j.phymed.2024.156354","DOIUrl":"https://doi.org/10.1016/j.phymed.2024.156354","url":null,"abstract":"<p><strong>Background: </strong>Specific treatment for rheumatoid arthritis (RA) is still an unmet need. Yu-Xue-Bi (YXB) capsule effectively treats RA with blood stasis syndrome (BS). However, its mechanism remains unclear.</p><p><strong>Purpose: </strong>Exploring and elucidating the therapeutic effect and pharmacological mechanism of YXB capsule in treating RA.</p><p><strong>Methods: </strong>This study identified differentially expressed genes (DEGs) in patients with RA and BS compared to healthy controls using clinical transcriptomics data. Clinical symptoms of RA and BS, and the related genes were collected from the SoFDA and HPO databases. Candidate bioactive constituents in YXB were identified via UPLC-QTOF/MS and evaluated using ADMET rules. Putative targets were predicted, and a network linking disease-related DEGs and drug targets was constructed. Key targets were screened utilizing random walk-with-restart (RWR) algorithms and verified through experiments using rat models of collagen-induced arthritis with BS (CIA-BS model) in vivo.</p><p><strong>Results: </strong>We found 1220 DEGs along with 976 clinical symptom-related genes, as RA with BS-related genes. Chemical profiling identified 193 YXB constituents, with 98 meeting optimal ADMET criteria. We predicted 459 putative targets for these constituents. Network calculations screened 209 key targets, 129 RA with BS-related genes and 92 YXB targets involved in immune inflammation, blood stagnation, and hyperalgesia imbalance. Notably, the SUCNR1/HIF-1α/TRPV1 axis was enriched by YXB targets against RA with BS. Experimentally, YXB inhibited inflamed joint deterioration, including synovial inflammation, cartilage damage and bone erosion, relieving mechanical and cold allodynia hyperglasia. It reversed hemorrheology and vascular function in CIA-BS rats, restoring SDHB and eNOS expression, preventing SDHA, SUCNR1 and HIF-1α activation, reducing SUCN, TNF-α and IL-1β production, and TRPV1 and TRPA1 expression.</p><p><strong>Conclusion: </strong>Our data support YXB's therapeutic effects on aggressive RA-BS by modulating the SUCNR1/HIF-1α/TRPV1 axis.</p>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"136 ","pages":"156354"},"PeriodicalIF":6.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative chloroplast genome analyses provide new insights into molecular markers for distinguishing Arnebiae Radix and its substitutes (tribe Lithospermeae, Boraginaceae) 比较叶绿体基因组分析为鉴别羊藿科及其代用物提供了新的分子标记。
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-01 DOI: 10.1016/j.phymed.2024.156338
Sheng Wang , Yiheng Wang , Jiahui Sun , Xingyong Cui , Enze Li , Ruishan Wang , Qi Li , Pengfei Zhang , Wenpan Dong , Lanping Guo , Luqi Huang

Background

Arnebiae Radix has long been used in traditional medicine for its pleiotropic properties. However, distinguishing Arnebiae Radix from its substitutes or closely related species has been challenging due to limited phenotypic characteristics.

Purpose

We aimed to identify the molecular markers for distinguishing Arnebiae Radix from its confusion species.

Study design

Chloroplast genome sequences were used to identify the markers.

Methods

Chloroplast genomes from 15 species across five genera, including all historically used source plants, were sequenced and assembled.

Results

The results revealed significant similarities across all chloroplast genomes in terms of structure, size, gene content, repeat sequences pattens, and codon usage patterns. Phylogenetic analysis showed that the genera Lithospermum, Buglossoides, and Aegonychon formed one clade, while Arnebia guttata, Ar. decumbens, and Ar. euchroma form another. Despite most regions of the chloroplast genomes are highly conserved, three regions—petA-psbJ, ndhF-rpl32, and ycf1—exhibited high variability among difference species, providing high-resolution markers for species identification. Specifically, 376 and 325 species-specific sites were identified in Ar. euchroma and Ar. guttata, respectively. Additionally, four species-specific sites were identified as novel molecular markers, potentially aiding in distinguishing Arnebiae Radix and its confusion or substitute species.

Conclusion

This study provided new genetic insights for differentiating Arnebiae Radix and its confusion species, paving the way for further exploration of these medicinal plants.
背景:紫杉因其多效性而被广泛应用于传统医学中。然而,由于其有限的表型特征,从其替代品或近缘种中区分紫杉一直具有挑战性。目的:寻找鉴别紫杉及其混种的分子标记。研究设计:利用叶绿体基因组序列鉴定标记。方法:对5属15个种的叶绿体基因组进行测序和组装,包括所有历史上使用的来源植物。结果:结果揭示了所有叶绿体基因组在结构、大小、基因含量、重复序列模式和密码子使用模式方面的显著相似性。系统发育分析表明,石芋属、Buglossoides属和Aegonychon属为一个分支,Arnebia guttata属、Ar. decumbens属和Ar. euchroma属为另一个分支。尽管叶绿体基因组的大部分区域高度保守,但peta - psbj、ndhF-rpl32和ycf1这三个区域在不同物种间表现出很高的变异性,为物种鉴定提供了高分辨率的标记。其中,euchroma和arr . guttata分别鉴定出376个和325个种特异性位点。此外,还鉴定出了4个种特异性位点作为新的分子标记,可能有助于鉴别紫杉属及其混淆种或替代种。结论:本研究为鉴别紫杉属及其混种提供了新的遗传学见解,为进一步开发紫杉属药用植物奠定了基础。
{"title":"Comparative chloroplast genome analyses provide new insights into molecular markers for distinguishing Arnebiae Radix and its substitutes (tribe Lithospermeae, Boraginaceae)","authors":"Sheng Wang ,&nbsp;Yiheng Wang ,&nbsp;Jiahui Sun ,&nbsp;Xingyong Cui ,&nbsp;Enze Li ,&nbsp;Ruishan Wang ,&nbsp;Qi Li ,&nbsp;Pengfei Zhang ,&nbsp;Wenpan Dong ,&nbsp;Lanping Guo ,&nbsp;Luqi Huang","doi":"10.1016/j.phymed.2024.156338","DOIUrl":"10.1016/j.phymed.2024.156338","url":null,"abstract":"<div><h3>Background</h3><div><em>Arnebiae Radix</em> has long been used in traditional medicine for its pleiotropic properties. However, distinguishing <em>Arnebiae Radix</em> from its substitutes or closely related species has been challenging due to limited phenotypic characteristics.</div></div><div><h3>Purpose</h3><div>We aimed to identify the molecular markers for distinguishing <em>Arnebiae Radix</em> from its confusion species.</div></div><div><h3>Study design</h3><div>Chloroplast genome sequences were used to identify the markers.</div></div><div><h3>Methods</h3><div>Chloroplast genomes from 15 species across five genera, including all historically used source plants, were sequenced and assembled.</div></div><div><h3>Results</h3><div>The results revealed significant similarities across all chloroplast genomes in terms of structure, size, gene content, repeat sequences pattens, and codon usage patterns. Phylogenetic analysis showed that the genera <em>Lithospermum, Buglossoides</em>, and <em>Aegonychon</em> formed one clade, while <em>Arnebia guttata, Ar. decumbens</em>, and <em>Ar. euchroma</em> form another. Despite most regions of the chloroplast genomes are highly conserved, three regions—<em>petA-psbJ, ndhF-rpl32</em>, and <em>ycf1</em>—exhibited high variability among difference species, providing high-resolution markers for species identification. Specifically, 376 and 325 species-specific sites were identified in <em>Ar. euchroma</em> and <em>Ar. guttata</em>, respectively. Additionally, four species-specific sites were identified as novel molecular markers, potentially aiding in distinguishing <em>Arnebiae Radix</em> and its confusion or substitute species.</div></div><div><h3>Conclusion</h3><div>This study provided new genetic insights for differentiating <em>Arnebiae Radix</em> and its confusion species, paving the way for further exploration of these medicinal plants.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"136 ","pages":"Article 156338"},"PeriodicalIF":6.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142896893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isobicyclogermacrenal ameliorates hippocampal ferroptosis involvement in neurochemical disruptions and neuroinflammation induced by sleep deprivation in rats 异环大肾改善大鼠睡眠剥夺引起的神经化学破坏和神经炎症中的海马铁下垂。
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-01 DOI: 10.1016/j.phymed.2024.156306
Ao Yan , Zhejin Li , Yuanwei Gao , Fanglong Hu , Shuo Han , Fengjie Liu , Zhongcheng Liu , Jinting Chen , Chunmao Yuan , Chengyan Zhou

Background

Sleep deprivation (SLD) is a widespread condition that disrupts physiological functions and may increase mortality risk. Valeriana officinalis, a traditional medicinal herb known for its sedative and hypnotic properties, contains isobicyclogermacrenal (IG), a newly isolated active compound. However, research on the therapeutic potential of IG for treating SLD remains limited.

Methods

In this study, IG was extracted and characterized from Valeriana officinalis, and an SLD model was established in rats using p-chlorophenylalanine (PCPA). Behavioral tests and pathological studies were conducted to assess the effects of IG on SLD, and transcriptomic and metabolomic analyses were utilized to investigate its underlying mechanisms.

Results

IG administration significantly improved the cognitive performance of SLD rats in behavioral tests and ameliorated histological injuries in the hippocampus and cerebral cortex. IG treatment increased the levels of brain-derived neurotrophic factor (BDNF) and neurotransmitters such as serotonin (5-HT) in SLD rats. Additionally, IG directly targets TFRC, thereby improving iron metabolism in the hippocampus. Comprehensive transcriptomic and metabolomic analyses revealed that the improvements from IG stemmed from the mitigation of abnormalities in iron metabolism, cholesterol metabolism, and glutathione metabolism, leading to reduced oxidative stress, ferroptosis, and neuroinflammation in the hippocampus caused by SLD.

Conclusions

Collectively, these findings suggest that IG has the potential to ameliorate neurological damage and cognitive impairment caused by SLD, offering a novel strategy for protection against the adverse effects of SLD.
背景:睡眠剥夺(SLD)是一种广泛存在的疾病,它会破坏生理功能,并可能增加死亡风险。缬草(Valeriana officinalis)是一种以镇静和催眠特性而闻名的传统草药,它含有一种新分离的活性化合物异环大肾(IG)。然而,关于IG治疗SLD的潜力的研究仍然有限。方法:本研究从缬草中提取IG并对其进行表征,采用对氯苯丙氨酸(PCPA)建立大鼠SLD模型。通过行为试验和病理研究来评估IG对SLD的影响,并利用转录组学和代谢组学分析来研究其潜在机制。结果:IG显著改善了大鼠行为测试中的认知能力,改善了海马和大脑皮层的组织学损伤。IG处理增加了SLD大鼠脑源性神经营养因子(BDNF)和神经递质如血清素(5-HT)的水平。此外,IG直接作用于TFRC,从而改善海马体内的铁代谢。综合转录组学和代谢组学分析显示,IG的改善源于铁代谢、胆固醇代谢和谷胱甘肽代谢异常的缓解,从而减少了SLD引起的海马氧化应激、铁下沉和神经炎症。结论:总的来说,这些发现表明IG有可能改善SLD引起的神经损伤和认知障碍,为防止SLD的不良反应提供了一种新的策略。
{"title":"Isobicyclogermacrenal ameliorates hippocampal ferroptosis involvement in neurochemical disruptions and neuroinflammation induced by sleep deprivation in rats","authors":"Ao Yan ,&nbsp;Zhejin Li ,&nbsp;Yuanwei Gao ,&nbsp;Fanglong Hu ,&nbsp;Shuo Han ,&nbsp;Fengjie Liu ,&nbsp;Zhongcheng Liu ,&nbsp;Jinting Chen ,&nbsp;Chunmao Yuan ,&nbsp;Chengyan Zhou","doi":"10.1016/j.phymed.2024.156306","DOIUrl":"10.1016/j.phymed.2024.156306","url":null,"abstract":"<div><h3>Background</h3><div>Sleep deprivation (SLD) is a widespread condition that disrupts physiological functions and may increase mortality risk. Valeriana officinalis, a traditional medicinal herb known for its sedative and hypnotic properties, contains isobicyclogermacrenal (IG), a newly isolated active compound. However, research on the therapeutic potential of IG for treating SLD remains limited.</div></div><div><h3>Methods</h3><div>In this study, IG was extracted and characterized from <em>Valeriana officinalis</em>, and an SLD model was established in rats using p-chlorophenylalanine (PCPA). Behavioral tests and pathological studies were conducted to assess the effects of IG on SLD, and transcriptomic and metabolomic analyses were utilized to investigate its underlying mechanisms.</div></div><div><h3>Results</h3><div>IG administration significantly improved the cognitive performance of SLD rats in behavioral tests and ameliorated histological injuries in the hippocampus and cerebral cortex. IG treatment increased the levels of brain-derived neurotrophic factor (BDNF) and neurotransmitters such as serotonin (5-HT) in SLD rats. Additionally, IG directly targets TFRC, thereby improving iron metabolism in the hippocampus. Comprehensive transcriptomic and metabolomic analyses revealed that the improvements from IG stemmed from the mitigation of abnormalities in iron metabolism, cholesterol metabolism, and glutathione metabolism, leading to reduced oxidative stress, ferroptosis, and neuroinflammation in the hippocampus caused by SLD.</div></div><div><h3>Conclusions</h3><div>Collectively, these findings suggest that IG has the potential to ameliorate neurological damage and cognitive impairment caused by SLD, offering a novel strategy for protection against the adverse effects of SLD.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"136 ","pages":"Article 156306"},"PeriodicalIF":6.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quercetin inhibits hydrogen peroxide-induced cleavage of heat shock protein 90 to prevent glutathione peroxidase 4 degradation via chaperone-mediated autophagy 槲皮素抑制过氧化氢诱导的热休克蛋白90裂解,通过伴侣介导的自噬阻止谷胱甘肽过氧化物酶4降解。
IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2025-01-01 DOI: 10.1016/j.phymed.2024.156286
Caiwang Peng , Hengli Li , Qingling Mao , Keyan Tang , Mu Sun , Qidi Ai , Yantao Yang , Fang Liu
<div><h3>Background</h3><div>Oxidative stress is caused by the accumulation of reactive oxygen species (ROS) and the depletion of free radical scavengers, which is closely related to ferroptosis in diseases. Quercetin, as a natural flavonoid compound, has been reported to have multiple pharmacological effects on the basis of its anti-oxidative and anti-ferroptotic activities. This study was designed to explore the specific mechanism of quercetin against ferroptosis induced by hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>).</div></div><div><h3>Methods</h3><div>The HT22 cells (mouse hippocampal neuronal cells) treated with 40 μg·ml<sup>-1</sup> H<sub>2</sub>O<sub>2</sub> were used to investigate the role of ferroptosis in oxidative stress damage and the regulation of quercetin (7.5, 15, 30 μmol·l<sup>-1</sup>), as evidenced by assessments of cell viability, morphological damage, Fe<sup>2+</sup> accumulation, and the expressions of ferroptotic-related proteins. The changes in the expression levels of glutathione peroxidase 4 (GPX4), heat shock cognate protein 70 (HSC70), lysosomal-associated membrane protein 2a (LAMP-2a), and heat shock protein (HSP90) were assessed by qPCR, western blotting (WB) and immunofluorescence (IF) assays. Additionally, the interactions of GPX4, HSC70, LAMP-2a, and HSP90 were examined by co-immunoprecipitation (Co-IP) assay to elucidate the impact of quercetin on the degradation pathway of GPX4 and the CMA pathway. To further explore the regulatory mechanism of quercetin, the si-LAMP-2a and HSP90 mutant cells were conducted.</div></div><div><h3>Results</h3><div>Pretreatment with 30 μmol·l<sup>-1</sup> quercetin for 6 h significantly enhanced the survival rate (<em>p</em> < 0.05), maintained cell morphology, and inhibited Fe<sup>2+</sup> levels in HT22 cells exposed to H<sub>2</sub>O<sub>2</sub> (40 μg·ml<sup>-1</sup>). HT22 cells under oxidative stress showed lower expressions of GPX4 and ferritin heavy chain 1 (FTH1), and a higher level of Acyl-CoA synthetase long-chain family member 4 (ACSL4) (<em>p</em> < 0.05). And quercetin significantly reversed the expressions of these ferroptotic proteins (<em>p</em> < 0.05). Moreover, the autophagic lysosomal pathway inhibitor CQ effectively increased the expression of GPX4 in oxidative stress cell model. Further study showed that H<sub>2</sub>O<sub>2</sub> increased the activity of macroautophagy and chaperone-mediated autophagy (CMA), while quercetin notably suppressed the levels of microtubule-associated protein light chain 3 Ⅱ (LC3 Ⅱ), LAMP-2a, and the activity of lysosomes (<em>p</em> < 0.01). Additionally, quercetin disrupted the interactions of GPX4, HSC70, and LAMP-2a, reduced cellular levels of CMA by decreasing the cleaved HSP90 (c-HSP90), and these effects were reversed in the R347 mutant HT22 cells.</div></div><div><h3>Conclusions</h3><div>Quercetin has a significantly protective effect on oxidative stress cell model through the inhibition on ferroptosis, wh
背景:氧化应激是由活性氧(ROS)的积累和自由基清除剂的耗竭引起的,与疾病中的铁变态反应密切相关。据报道,槲皮素作为一种天然黄酮类化合物,在抗氧化和抗铁血病活性的基础上具有多种药理作用。本研究旨在探讨槲皮素抗过氧化氢(H2O2)诱导的铁突变的具体机制:方法:用 40 μg-ml-1 H2O2 处理 HT22 细胞(小鼠海马神经元细胞),通过评估细胞活力、形态损伤、Fe2+ 积累和铁中毒相关蛋白的表达,研究铁中毒在氧化应激损伤中的作用以及槲皮素(7.5、15、30 μmol-l-1)的调节作用。通过 qPCR、Western 印迹(WB)和免疫荧光(IF)检测评估了谷胱甘肽过氧化物酶 4(GPX4)、热休克同源蛋白 70(HSC70)、溶酶体相关膜蛋白 2a(LAMP-2a)和热休克蛋白(HSP90)表达水平的变化。此外,还通过共免疫沉淀(Co-IP)检测了 GPX4、HSC70、LAMP-2a 和 HSP90 的相互作用,以阐明槲皮素对 GPX4 降解途径和 CMA 途径的影响。为了进一步探索槲皮素的调控机制,研究人员对 si-LAMP-2a 和 HSP90 突变细胞进行了研究:30 μmol-l-1槲皮素预处理6小时可显著提高暴露于H2O2(40 μg-ml-1)的HT22细胞的存活率(p < 0.05),维持细胞形态,抑制Fe2+水平。氧化应激下的 HT22 细胞 GPX4 和铁蛋白重链 1(FTH1)的表达量较低,而 Acyl-CoA synthetase long-chain family member 4(ACSL4)的表达量较高(p < 0.05)。而槲皮素能明显逆转这些铁蛋白的表达(p < 0.05)。此外,自噬溶酶体途径抑制剂 CQ 能有效提高氧化应激细胞模型中 GPX4 的表达。进一步的研究表明,H2O2 增加了大自噬和伴侣介导的自噬(CMA)的活性,而槲皮素显著抑制了微管相关蛋白轻链 3 Ⅱ(LC3 Ⅱ)、LAMP-2a 的水平和溶酶体的活性(p < 0.01)。此外,槲皮素还能破坏 GPX4、HSC70 和 LAMP-2a 的相互作用,通过减少裂解的 HSP90(c-HSP90)来降低细胞中的 CMA 水平,这些作用在 R347 突变体 HT22 细胞中被逆转:结论:槲皮素通过抑制铁跃迁对氧化应激细胞模型有明显的保护作用,而铁跃迁与通过CMA降解GPX4有关。槲皮素能降低H2O2诱导的c-HSP90的水平,从而通过与HSP90的R347结合降低CMA的活性。
{"title":"Quercetin inhibits hydrogen peroxide-induced cleavage of heat shock protein 90 to prevent glutathione peroxidase 4 degradation via chaperone-mediated autophagy","authors":"Caiwang Peng ,&nbsp;Hengli Li ,&nbsp;Qingling Mao ,&nbsp;Keyan Tang ,&nbsp;Mu Sun ,&nbsp;Qidi Ai ,&nbsp;Yantao Yang ,&nbsp;Fang Liu","doi":"10.1016/j.phymed.2024.156286","DOIUrl":"10.1016/j.phymed.2024.156286","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Oxidative stress is caused by the accumulation of reactive oxygen species (ROS) and the depletion of free radical scavengers, which is closely related to ferroptosis in diseases. Quercetin, as a natural flavonoid compound, has been reported to have multiple pharmacological effects on the basis of its anti-oxidative and anti-ferroptotic activities. This study was designed to explore the specific mechanism of quercetin against ferroptosis induced by hydrogen peroxide (H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;The HT22 cells (mouse hippocampal neuronal cells) treated with 40 μg·ml&lt;sup&gt;-1&lt;/sup&gt; H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; were used to investigate the role of ferroptosis in oxidative stress damage and the regulation of quercetin (7.5, 15, 30 μmol·l&lt;sup&gt;-1&lt;/sup&gt;), as evidenced by assessments of cell viability, morphological damage, Fe&lt;sup&gt;2+&lt;/sup&gt; accumulation, and the expressions of ferroptotic-related proteins. The changes in the expression levels of glutathione peroxidase 4 (GPX4), heat shock cognate protein 70 (HSC70), lysosomal-associated membrane protein 2a (LAMP-2a), and heat shock protein (HSP90) were assessed by qPCR, western blotting (WB) and immunofluorescence (IF) assays. Additionally, the interactions of GPX4, HSC70, LAMP-2a, and HSP90 were examined by co-immunoprecipitation (Co-IP) assay to elucidate the impact of quercetin on the degradation pathway of GPX4 and the CMA pathway. To further explore the regulatory mechanism of quercetin, the si-LAMP-2a and HSP90 mutant cells were conducted.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Pretreatment with 30 μmol·l&lt;sup&gt;-1&lt;/sup&gt; quercetin for 6 h significantly enhanced the survival rate (&lt;em&gt;p&lt;/em&gt; &lt; 0.05), maintained cell morphology, and inhibited Fe&lt;sup&gt;2+&lt;/sup&gt; levels in HT22 cells exposed to H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; (40 μg·ml&lt;sup&gt;-1&lt;/sup&gt;). HT22 cells under oxidative stress showed lower expressions of GPX4 and ferritin heavy chain 1 (FTH1), and a higher level of Acyl-CoA synthetase long-chain family member 4 (ACSL4) (&lt;em&gt;p&lt;/em&gt; &lt; 0.05). And quercetin significantly reversed the expressions of these ferroptotic proteins (&lt;em&gt;p&lt;/em&gt; &lt; 0.05). Moreover, the autophagic lysosomal pathway inhibitor CQ effectively increased the expression of GPX4 in oxidative stress cell model. Further study showed that H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; increased the activity of macroautophagy and chaperone-mediated autophagy (CMA), while quercetin notably suppressed the levels of microtubule-associated protein light chain 3 Ⅱ (LC3 Ⅱ), LAMP-2a, and the activity of lysosomes (&lt;em&gt;p&lt;/em&gt; &lt; 0.01). Additionally, quercetin disrupted the interactions of GPX4, HSC70, and LAMP-2a, reduced cellular levels of CMA by decreasing the cleaved HSP90 (c-HSP90), and these effects were reversed in the R347 mutant HT22 cells.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Quercetin has a significantly protective effect on oxidative stress cell model through the inhibition on ferroptosis, wh","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"136 ","pages":"Article 156286"},"PeriodicalIF":6.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Phytomedicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1